NCT07010367

Brief Summary

This study is a randomized controlled trial that explores how a specific acupuncture treatment might help people with functional constipation. The investigators are testing the idea that a treatment called "acupuncture at the Baliao acupoints" could work by changing the way certain parts of the brain connect and function. These brain changes might help improve gut function and relieve constipation symptoms. The investigators will work with people who have functional constipation. Some participants will receive the real Baliao acupoint thread embedding, while others will get a sham acupuncture as a comparison. Using special brain imaging techniques, the investigators will look at how the brain's connections and structures change. The investigators will also track how often participants have bowel movements, the consistency of their stools, and their overall symptoms and quality of life. By comparing these results, the investigators hope to understand how the Baliao acupoint treatment works and why it might be effective for constipation.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Jun 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jun 2025Jul 2026

First Submitted

Initial submission to the registry

May 26, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 8, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

June 20, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2026

Last Updated

June 8, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

May 26, 2025

Last Update Submit

June 6, 2025

Conditions

Keywords

functional constipationfMRI

Outcome Measures

Primary Outcomes (1)

  • Spontaneous bowel movements

    Spontaneous bowel movements (SBMs) refers to the frequency of bowel movements that occur without the use of any medications or other aids within the past 24 hours. These data are collected from the constipation diaries filled out daily by patients with functional constipation (FC) to determine the weekly count of SBMs. The data collection time points include before treatment and at 2, 4, 6, and 8 weeks after treatment.

    SBMs will be recorded 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment.

Secondary Outcomes (2)

  • PAC-SYM

    PAC-SYM will be assessed at 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment

  • PAC-QOL

    PAC-QOL will be accessed 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment.

Other Outcomes (3)

  • SAS

    SAS will be accessed 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment.

  • SDS

    SDS will be accessed 1 week before treatment and at 2, 4, 6, and 8 weeks after treatment.

  • Amplitude of Low-Frequency Fluctuations

    at 1 week before treatment and 4 weeks after treatment

Study Arms (2)

acupuncture group

EXPERIMENTAL

Patients will receive acupuncture at Baliao acupuncts.

Procedure: Acupuncture

sham group

SHAM COMPARATOR

Patients will receive sham acupuncture treatment.

Procedure: Sham acupuncture

Interventions

AcupuncturePROCEDURE

Patients will be instructed to lie in the supine position. After strict disinfection of the acupoints area, acupuncture needles will be inserted into the Baliao points (inserted at the surface projections of the first, second, and third pairs of sacral foramina, with a depth of 3-4 cm). The treatment will be administered five times per week, with each session lasting 30 minutes, for a total of two weeks.

acupuncture group

Patients will be instructed to lie in the supine position. After strict disinfection of the sham acupoints area, acupuncture needles will be inserted lateral to the surface projections of the first, second, and third pairs of sacral foramina, with a depth of 1 cm.The treatment will be administered five times per week, with each session lasting 30 minutes, for a total of two weeks.

sham group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age:18 years or older.
  • Diagnosed with functional constipation according to the Rome IV criteria.
  • The participant has not received any treatment for functional constipation in the past two weeks (except for emergency interventions).
  • Right-handed.
  • Signed a written informed consent form to participate in this study.

You may not qualify if:

  • Presence of organic constipation, drug-induced constipation, or systemic constipation.
  • Presence of metallic foreign bodies in the body, pacemakers, or other contraindications for MRI examination.
  • Communication disorders or unwillingness to cooperate with treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2025

First Posted

June 8, 2025

Study Start

June 20, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 30, 2026

Last Updated

June 8, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Individual Participant Data contains highly sensitive and personal information about study participants. Sharing IPD could potentially compromise participant privacy and confidentiality.